Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Ovarian Cancer treatment details. Chemotherapy. Dharamshila Cancer Hospital, Delhi, India

Survival: 26.0 months
Toxicity Grade: 4
Treatments: Chemotherapy
Drugs: Gemzar
Country: India
City/State/Province: Delhi
Hospital: Dharamshila Cancer Hospital
Journal: Link
Date: 7/2005

Patients: This Phase II study involved 45 women with advanced epithelial ovarian cancer (stage III or IV). The median age was 52. Metastatic sites included liver, pleura, and spleen.

Treatment: The treatment consisted of three chemotherapeutic drugs: cisplatin, paclitaxel, and gemcitabine.

Toxicity: Grade 3-4 toxicities included hematological toxicities (neutropenia, anemia, thrombocytopenia), nausea/vomiting, constipation, and uremia.

Results: The overall survival was 26 months.

Support: Eli Lilly financially supported this study. Eli Lilly manufactures and markets gemcitabine.

Correspondence: B.S. Aswathy, MD

E-mail to a Friend Email Physician More Information